NICE – Medtech Innovation Briefing for Visensia – The Safety Index (MIB36)

Date Published: 27th August 2015

OBS Medical are pleased to announce the publication of the Medtech Innovation Briefing (MIB) by the National Institute for Health and Care Excellence (NICE) on Visensia – The Safety Index for the early detection of deteriorating vital signs in adults in hospital.

To find out more about the Nice MIB please follow the link (image) below to the NICE website.

NICE MIB36 Visensia The Safety Index

About OBS Medical Limited

OBS Medical is the global leader in the development of predictive algorithms for identifying critical instabilities in patients that are not picked up by traditional methods.

Our Mission is to provide healthcare providers, device manufacturers and middleware companies with a simple, unambiguous call to action for all caregivers involved in the Continuum of Care, to reference and respond to patient deterioration, helping to improve clinical outcomes and patient safety through;

Simplification, Risk Identification and Prevention – Visensia® - The Safety Index™

OBS Medical – Data for Life™

For more information about Visensia® please:
Call: +44 (0)1235 432050 or visit the OBS website: www.obsmedical.com
Email: info@obsmedical.com

Our site uses cookies. If you continue to use our site you consent to us using cookies. Close

MENU